Adjuvant sunitinib for high-risk-resected renal cell carcinoma: a meta-analysis of ASSURE and S-TRAC trials

被引：13
|
作者：
Gyawali, B. [1 ]
Ando, Y. [1 ]
机构：
[1] Nagoya Univ, Grad Sch Med, Dept Clin Oncol & Chemotherapy, Nagoya, Aichi, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷 / 04期
关键词：
D O I：
10.1093/annonc/mdw667
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：898 / 899
页数：2
相关论文
共 50 条
  • [21] Neutrophil-to-lymphocyte ratio as a potential prognostic factor of disease-free survival in high-risk renal cell carcinoma: Analysis of the S-TRAC trial.
    Patel, Anup
    Ravaud, Alain
    Motzer, Robert J.
    Pantuck, Allan J.
    Staehler, Michael D.
    Escudier, Bernard
    Martini, Jean-Francois
    Krishnaswami, Sriram
    Casey, Michelle
    Lechuga, Mariajose
    Lin, Xun
    George, Daniel J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma after Nephrectomy
    Klatte, Tobias
    EUROPEAN UROLOGY, 2017, 71 (05) : 835 - 836
  • [23] Re: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy
    Salmasi, Amirali
    Faiena, Izak
    Drakaki, Alexandra
    Pantuck, Allan J.
    EUROPEAN UROLOGY, 2018, 74 (01) : 119 - 121
  • [24] Commentary on: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy
    Struss, Werner J.
    Black, Peter C.
    UROLOGY, 2017, 105 : 13 - 13
  • [25] Commentary on: Adjuvant Sunitinib in High-risk Renal-cell Carcinoma After Nephrectomy
    Ravaud, A.
    Motzer, R. J.
    Pandha, H. S.
    UROLOGY, 2017, 105 : 13 - 13
  • [26] Adjuvant immunotherapy in renal cell carcinoma: a systematic review and meta-analysis
    Riveros, Carlos
    Huang, Emily
    Ranganathan, Sanjana
    Klaassen, Zachary
    Rini, Brian
    Wallis, Christopher J. D.
    Satkunasivam, Raj
    BJU INTERNATIONAL, 2023, 131 (05) : 553 - 561
  • [27] Sunitinib for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trials Data
    Michael Moran
    Dana Nickens
    Katherine Adcock
    Meg Bennetts
    Arial Desscan
    Natalie Charnley
    Kate Fife
    Targeted Oncology, 2019, 14 : 405 - 416
  • [28] Sunitinib for metastatic renal cell carcinoma: A systematic review and meta-analysis of real world and clinical trials data.
    Moran, Michael
    Nickens, Dana J.
    Adcock, Katherine
    Desscan, Arial
    Bennetts, Meg
    Charnley, Natalie
    Fife, Kate
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [29] Sunitinib for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trials Data
    Moran, Michael
    Nickens, Dana
    Adcock, Katherine
    Bennetts, Meg
    Desscan, Arial
    Charnley, Natalie
    Fife, Kate
    TARGETED ONCOLOGY, 2019, 14 (04) : 405 - 416
  • [30] Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial
    Ristau, Benjamin T.
    Manola, Judi
    Haas, Naomi B.
    Heng, Daniel Y. C.
    Messing, Edward M.
    Wood, Christopher G.
    Kane, Christopher J.
    DiPaola, Robert S.
    Uzzo, Robert G.
    JOURNAL OF UROLOGY, 2018, 199 (01): : 53 - 59
12345